Department of Anaesthesiology, Intensive Care, Emergency Care and Pain Clinic, Helsinki University Central Hospital, Helsinki, Finland.
World Neurosurg. 2010 Feb;73(2):79-83; discussion e9. doi: 10.1016/j.surneu.2009.06.018. Epub 2009 Oct 8.
Rupture of an intracranial aneurysm during surgical clipping may have devastating consequences. Should this happen all methods ought to be considered to stop the bleeding. A short-term cardiac arrest induced by adenosine could be a feasible method to help the surgeon. We present our experiences in the administration of adenosine during an intraoperative aneurysm rupture.
Medical records of patients who underwent surgical clipping of a cerebral arterial aneurysm were reviewed from 2 university hospitals' operative database in the years 2003 to 2008. Patients were included in this study if adenosine had been administered during intraoperative rupture of an aneurysm.
Altogether, 16 of 1014 patients were identified with the use of adenosine during an intraoperative rupture of an aneurysm. All of the patients had sinus rhythm and normotension before the rupture of the aneurysm. Twelve patients were administered a single dose of adenosine and 4 multiple boluses for induction of cardiac arrest; the median (range) total dose was 12 (6-18) mg and 27 (18-87) mg, respectively. The clipping of the aneurysm and the recovery of circulation were uneventful in all cases. In a subgroup analysis according to patient outcome as alive/dead, the pre- and postoperative neurologic condition correlated with the outcome, whereas adenosine did not have any effect on the patient outcome.
In a case of a sudden aneurysm rupture, adenosine-induced circulatory arrest could be a safe option to facilitate clipping of an aneurysm. However, if adenosine is used, a very close collaboration between the surgeon and the anesthesiologist is required.
颅内动脉瘤破裂在手术夹闭过程中可能会带来灾难性的后果。如果发生这种情况,应考虑所有方法来止血。腺苷诱导的短期心脏骤停可能是帮助外科医生的可行方法。我们介绍了在术中动脉瘤破裂时使用腺苷的经验。
从 2003 年至 2008 年,我们回顾了两所大学医院手术数据库中接受脑动脉动脉瘤手术夹闭的患者的病历。如果在术中动脉瘤破裂期间使用了腺苷,则将患者纳入本研究。
总共在 1014 例患者中有 16 例在术中动脉瘤破裂期间使用了腺苷。所有患者在动脉瘤破裂前均有心律窦性和正常血压。12 例患者单次给予腺苷剂量,4 例患者多次给予腺苷剂量以诱导心脏骤停;中位数(范围)总剂量分别为 12(6-18)mg 和 27(18-87)mg。在所有病例中,夹闭动脉瘤和循环恢复均顺利。根据患者存活/死亡的预后亚组分析,术前和术后的神经状况与预后相关,而腺苷对患者预后没有影响。
在突发动脉瘤破裂的情况下,腺苷诱导的循环骤停可能是便于夹闭动脉瘤的安全选择。但是,如果使用腺苷,则需要外科医生和麻醉师之间非常密切的合作。